Device Linac Solutions (Mr-Linac)

Elekta Unity

Payments companies reported to CMS as associated with Elekta Unity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$46Kassociated payments (2023-2025)

115clinicians with associated payments

7companies reporting

By year

2023 $13K

2024 $2,916

2025 $30K

Payments reported as associated with Elekta Unity, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Radiation Oncology $25K

Therapeutic Radiology $20K

Pediatrics $143

Hematology & Oncology $67.08

General Practice $65.55

Physician Assistant $49.80

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Elekta Unity

These are the largest totals companies reported as associated with Elekta Unity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Christopher Crane	New York, NY	Therapeutic Radiology	$19,239.89
Himanshu Nagar	New York, NY	Radiation Oncology	$1,910.18
Robert Timmerman	Dallas, TX	Radiation Oncology	$1,551.89
Chad Tang	Houston, TX	Radiation Oncology	$1,511.85
Michael Zelefsky	New York, NY	Radiation Oncology	$1,500.00
Stephen Rosenberg	Madison, WI	Radiation Oncology	$1,286.66
Ritchie Stevens	Las Vegas, NV	Radiation Oncology	$1,094.06
Christine Cha	Bellingham, WA	Radiation Oncology	$1,083.15
Evan Wuthrick	Columbus, OH	Radiation Oncology	$1,068.92
Matthew Cavey	Fort Worth, TX	Radiation Oncology	$1,011.63

Prescribed Elekta Unity?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.